IMUGENE LIMITED ACN 009 179 551 WWW.IMUGENE.COM info@imugene.com ASX Announcement Imugene Reports one Complete Response and one Partial Response in BTKi Combination Cohort of azer-cel Phase 1b Trial •Two further responses achieved at Day 28: one Complete Response (CR) in MantleCell...